Measuring vitamin D

Australian Prescriber

Volumn 38, Issue 1, 2015, Pages 12-15

  Glendenning, Paul ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

25 hydroxyvitamin D; Vitamin D deficiency; Vitamin D supplements; Vitamin D tests

Indexed keywords

25 HYDROXYVITAMIN D; CALCITRIOL; COLECALCIFEROL; PARATHYROID HORMONE; VITAMIN D; VITAMIN D RECEPTOR;

ARTICLE; BONE DENSITY; BONE TURNOVER; CALCIUM ABSORPTION; FRAGILITY FRACTURE; HUMAN; IMMUNOASSAY; LIGHT EXPOSURE; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; OSTEOMALACIA; OUTCOME ASSESSMENT; PROTEIN BINDING; RANDOMIZED CONTROLLED TRIAL (TOPIC); RICKETS; RISK ASSESSMENT; SYSTEMATIC REVIEW (TOPIC); ULTRAVIOLET B RADIATION; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION;

EID: 84922206936     PISSN: 03128008     EISSN: 18393942     Source Type: Journal    
DOI: 10.18773/austprescr.2015.004     Document Type: Article

References (17)

1. Glendenning P, Prince RL. What is the therapeutic target level of 25-hydroxyvitamin D in osteoporosis and how accurately can we measure it? Intern Med J 2012;42:1069-72.
2. Joshi D, Center JR, Eisman JA. Vitamin D deficiency in adults. Aust Prescr 2010;33:103-6.
3. Bouillon R, Van Schoor NM, Gielen E, Boonen S, Mathieu C, Vanderschueren D, et al. Optimal vitamin D status: a critical analysis on the basis of evidence-based medicine. J Clin Endocrinol Metab 2013;98:E1283-304.
4. Autier P, Boniol M, Pizot C, Mullie P. Vitamin D status and ill health: a systematic review. Lancet Diabetes Endocrinol 2014;2:76-89.
5. Chowdhury R, Kunutsor S, Vitezova A, Oliver-Williams C, Chowdhury S, Kiefte-de-Jong JC, et al. Vitamin D and risk of cause specific death: systematic review and meta-analysis of observational cohort and randomised intervention studies. BMJ 2014;348:g1903.
6. The Royal College of Pathologists of Australasia. Position statement. Use and interpretation of vitamin D testing. 2013. www.rcpa.edu.au/Library/College-Policies/Position-Statements/Use-and-Interpretation-of-Vitamin-D-Testing [cited 2015 Jan 7]
7. Glendenning P, Inderjeeth CA. Vitamin D: methods of 25 hydroxyvitamin D analysis, targeting at risk populations and selecting thresholds of treatment. Clin Biochem 2012;45:901-6.
8. Cauley JA, Lacroix AZ, Wu L, Horwitz M, Danielson ME, Bauer DC, et al. Serum 25-hydroxyvitamin D concentrations and risk for hip fractures. Ann Intern Med 2008;149:242-50.
9. Malabanan A, Veronikis IE, Holick MF. Redefining vitamin D insufficiency. Lancet 1998;351:805-6.
10. Lips P. Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. Endocr Rev 2001;22:477-501.
11. Jesudason D, Need AG, Horowitz M, O’Loughlin PD, Morris HA, Nordin BE. Relationship between serum 25-hydroxyvitamin D and bone resorption markers in vitamin D insufficiency. Bone 2002;31:626-30.
12. Ensrud KE, Taylor BC, Paudel ML, Cauley JA, Cawthorn BM, Cummings SR, et al. Serum 25-hydroxyvitamin D levels and rate of hip bone loss in older men. J Clin Endocrinol Metab 2009;94:2773-80.
13. Heaney RP, Dowell MS, Hale CA, Bendich A. Calcium absorption varies within the reference range for serum 25-hydroxyvitamin D. J Am Coll Nutr 2003;22:142-6.
14. Hansen KE, Jones AN, Lindstrom MJ, Davis LA, Engelke JA, Shafer MM. Vitamin D insufficiency: disease or no disease? J Bone Miner Res 2008;23:1052-60.
15. Chapuy MC, Arlot ME, Duboeuf F, Brun J, Crouzet B, Arnaud S, et al. Vitamin D3 and calcium to prevent hip fractures in the elderly women. N Engl J Med 1992;327:1637-42.
16. Glendenning P, Chew GT, Seymour HM, Gillett MJ, Goldswain PR, Inderjeeth CA, et al. Serum 25-hydroxyvitamin D levels in vitamin D-insufficient hip fracture patients after supplementation with ergocalciferol and cholecalciferol. Bone 2009;45:870-5.
17. Sanders KM, Stuart AL, Williamson EJ, Simpson JA, Kotowicz MA, Young D, et al. Annual high-dose oral vitamin D and falls and fractures in older women: a randomized controlled trial. JAMA 2010;303:1815-22.